Skip to main content
MicrobiologyOpen logoLink to MicrobiologyOpen
. 2019 Aug 13;8(8):e00901. doi: 10.1002/mbo3.901

Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen

John Osei Sekyere
PMCID: PMC6692521  PMID: 31410998

Subsequent to the publication of the paper by Osei Sekyere (2018), an error has been identified with the calculation of the drug resistance rates of the various antifungal drugs. The resistance rates of Candida auris to fluconazole and other antifungals were calculated by dividing the resistant isolates by all the retrieved isolates (n = 742) and multiplying the ratio by 100 instead of dividing the resistant isolates by the total number of isolates for which antifungal susceptibility data were available. A recalculation has been done for all these antifungal agents. With this new alteration, the resistance rate of fluconazole is within the range reported worldwide for C. auris. The correct Figure 3c is given below:

graphic file with name MBO3-8-e00901-g001.jpg

FLZ = fluconazole; VRZ = voriconazole; ITZ = itraconazole; PSZ = posaconazole; ISA = isoconazole; AMB = amphotericin B; FCN = flucytosine; ANF = anidulafungin; CFG = caspofungin; MCF = micafungin.

This error is sincerely regretted.

Supporting information

 

REFERENCE

  1. Osei Sekyere, J. (2018). Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen. MicrobiologyOpen, 7, e578 10.1002/mbo3.578 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

 


Articles from MicrobiologyOpen are provided here courtesy of Wiley

RESOURCES